DE69304279T2 - Fluorierte Analoge Vitamins D3 - Google Patents

Fluorierte Analoge Vitamins D3

Info

Publication number
DE69304279T2
DE69304279T2 DE69304279T DE69304279T DE69304279T2 DE 69304279 T2 DE69304279 T2 DE 69304279T2 DE 69304279 T DE69304279 T DE 69304279T DE 69304279 T DE69304279 T DE 69304279T DE 69304279 T2 DE69304279 T2 DE 69304279T2
Authority
DE
Germany
Prior art keywords
treatment
formula
compound
diseases
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69304279T
Other languages
German (de)
English (en)
Other versions
DE69304279D1 (de
Inventor
Enrico Giuseppe Baggiolini
Shian-Jan Shiuey
Milan Radoje Uskokovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69304279D1 publication Critical patent/DE69304279D1/de
Publication of DE69304279T2 publication Critical patent/DE69304279T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48—Halogenated derivatives
    • C07C35/52—Alcohols with a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69304279T 1992-05-20 1993-05-07 Fluorierte Analoge Vitamins D3 Expired - Fee Related DE69304279T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH161992 1992-05-20
US95750092A 1992-10-07 1992-10-07
US97178892A 1992-11-05 1992-11-05

Publications (2)

Publication Number Publication Date
DE69304279D1 DE69304279D1 (de) 1996-10-02
DE69304279T2 true DE69304279T2 (de) 1997-02-20

Family

ID=27173121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69304279T Expired - Fee Related DE69304279T2 (de) 1992-05-20 1993-05-07 Fluorierte Analoge Vitamins D3

Country Status (10)

Country Link
EP (1) EP0580968B1 (enExample)
JP (1) JP2670005B2 (enExample)
CN (1) CN1054601C (enExample)
AT (1) ATE141914T1 (enExample)
AU (1) AU671445B2 (enExample)
DE (1) DE69304279T2 (enExample)
DK (1) DK0580968T3 (enExample)
ES (1) ES2091515T3 (enExample)
GR (1) GR3021833T3 (enExample)
PH (1) PH30775A (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559149A (en) 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
TR25295A (tr) * 1992-02-26 1993-01-01 Simfer Dayanikli Tueketim Mamu Kati yakit yakan sobalar icin yanma havasi ön isitma sistemi
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
WO1997016193A1 (en) * 1995-10-27 1997-05-09 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
ES2196614T3 (es) 1997-09-08 2003-12-16 Hoffmann La Roche Analogos de la 1-3-dihidroxi-20,20-dialquil-vitamina d3.
GB9721156D0 (en) * 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
WO2004098612A2 (en) * 2003-05-07 2004-11-18 Ab Science Calcitriol analogs of uses thereof
DK2148684T3 (da) * 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
DE69130497T2 (de) * 1990-09-07 1999-04-22 Wisconsin Alumni Research Foundation, Madison, Wis. Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues

Also Published As

Publication number Publication date
CN1085211A (zh) 1994-04-13
ATE141914T1 (de) 1996-09-15
PH30775A (en) 1997-10-17
EP0580968B1 (en) 1996-08-28
JP2670005B2 (ja) 1997-10-29
EP0580968A2 (en) 1994-02-02
DE69304279D1 (de) 1996-10-02
AU671445B2 (en) 1996-08-29
AU3863593A (en) 1993-11-25
GR3021833T3 (enExample) 1997-02-28
CN1054601C (zh) 2000-07-19
EP0580968A3 (enExample) 1994-03-23
JPH0640975A (ja) 1994-02-15
ES2091515T3 (es) 1996-11-01
DK0580968T3 (da) 1996-10-14

Similar Documents

Publication Publication Date Title
DE69304279T2 (de) Fluorierte Analoge Vitamins D3
RU2134260C1 (ru) Аналоги витамина d3, способ их получения и фармацевтический препарат
US5512554A (en) Method of treating hyperproliferative skin diseases with fluorinated vitamin D3 analogs
DE69307871T2 (de) Neue vitamin-d analoge
EP0325279B1 (de) Dehydrocholecalciferolderivate
DE69702812T2 (de) Fluorinierte Vitamin D3 Derivate
US5750517A (en) Method of treating sebaceous gland diseases with vitamin D3 fluorinated analogs
DE69307478T2 (de) Vitamin D3 Derivate
DE69904442T2 (de) Cyclohexandiol-derivate
RU2142803C1 (ru) Агент для лечения заболеваний сальной железы и фармацевтическая композиция на его основе
DE69804606T2 (de) Cyclohexandiolderivate
DE69408244T2 (de) Vitamin D3-Analoge
EP0009776B1 (de) N-Monohydroxypropylamide, N-Dihydroxypropylamide und deren Acetonoide der all-E- und 13-Z-Retinsäure, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0009777A1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE69722064T2 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
EP0369288A1 (de) Pyranyläthyl-naphathalinderivate, ihre Herstellung und Verwendung als Heilmittel
EP0010209B1 (de) N-Benzoyl-retinylamine, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Mittel und die Verwendung dieser Verbindungen bei der Therapie und Prophylaxe von Praekanzerosen und Karzinomen der Haut
WO1997016423A1 (en) 24-homo-26,27-hexafluoro-cholecalciferols
KR20030063390A (ko) 레티페롤 유도체, 및 피부 질환 또는 광손상과 관련된증상을 치료하기 위한 그의 용도

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee